Spinal Simplicity is a company dedicated to the creation of innovative simple solutions for complex spinal problems. With a focus on quality, our products are designed to further enhance patient care while providing physicians with a greater array of minimally invasive devices. Our mission is to be the global leader in innovative, simplified surgical solutions, championing uncompromising quality.
Spinal Simplicity, LLC was founded in 2008 by Dr. Harold Hess, a practicing neurosurgeon, and Todd Moseley, an entrepreneur with over 30 years’ experience in orthopedics. The company began focusing on minimally invasive Lateral Approach lumbar fusion technology. In May 2011, Spinal Simplicity received CE approval for its initial product, the Minuteman, as well as ISO 13485 certification for its quality management system. In January 2015, FDA 510(k) clearance was granted for the Minuteman G3 device. Spinal Simplicity was granted FDA 510(k) clearance for the HA Minuteman® G3 in August of 2015 and for the HA Minuteman® G3R in January of 2017. These are significant milestones that allow Spinal Simplicity to compete in the fast-growing, minimally invasive spine market.
Our core values: Integrity, Patient First, Relentless Pursuit of Perfection, Teamwork
Location: United States, Kansas, Overland Park
Employees: 11-50
Phone: +1 913-451-4414
Founded date: 2008
Investors 3
Mentions in press and media 11
Date | Title | Description |
01.05.2024 | Spinal Simplicity announces FDA 510(k) Clearance of its Sacroiliac Joint System, the Patriot-SI Posterior Implant, With a Unique Hybrid Indication for Use | Patriot SI by Spinal Simplicity Spinal Simplicity announced the FDA 510(k) clearance of its Patriot-SI Posterior Implant System, designed for sacroiliac joint fusion in combination with the Liberty-SI lateral system. This clearance introduc... |
31.08.2023 | Prospective Study Demonstrates Clinically Significant Fusion Rates for Spinal Simplicity’s Minuteman Device | Prospective Study Demonstrates Clinically Significant Fusion Rates for Spinal Simplicity’s Minuteman Device August 31, 2023 / Nueterra Capital Marketing The American Society of Pain & Neuroscience’s Journal of Pain Research has publishe... |
19.05.2022 | Spinal Simplicity Announces New Senior Principal Scientist | Tom Hedman, PhD, Spinal Simplicity Senior Principal Scientist “I am tremendously excited to be joining the ambitious team at Spinal Simplicity to bring our game-changing nano-tethering tissue stabilization products to market.” OVERLAND PARK... |
10.05.2022 | Spinal Simplicity Acquires Intralink-Spine | Spinal Simplicity Acquires Intralink-Spine May 10, 2022 / Nueterra Capital Marketing Nueterra Capital portfolio company Spinal Simplicity has acquired Intralink-Spine, according to a press release. The acquisition includes Intralink-Spine’s... |
06.05.2022 | Spinal Simplicity announces the acquisition of Intralink-Spine and its novel injectable spinal disc stabilization product | Spinal Simplicity Acquires Intralink-Spine “The acquisition of this technology further demonstrates Spinal Simplicity’s commitment to developing and providing physicians and patients with cutting-edge, minimally invasive treatment options,”... |
03.05.2022 | Spinal Simplicity Launches Minuteman G5 Implant | Spinal Simplicity Launches Minuteman G5 Implant May 3, 2022 / Nueterra Capital Marketing As reported in Becker’s ASC Review, Nueterra Capital portfolio company Spinal Simplicity has launched its Minuteman G5 implant. The original Minuteman ... |
03.05.2022 | Spinal Simplicity Announces the launch of the Minuteman® G5 Implant | “Our new G5 implant has additional patented features that will provide numerous advantages for our doctors and the patients we all serve. The launch of our G5 implant is a great example of our company fulfilling one of our core values, the ... |
17.12.2021 | Spinal Simplicity Minuteman Lumbar Spinal Stenosis Indication for Use | Spinal Simplicity Minuteman Lumbar Spinal Stenosis Indication for Use “Our team could not be more thrilled with today’s news that Spinal Simplicity has been able to add Lumbar Spinal Stenosis as an FDA cleared indication for our Minuteman t... |
17.12.2021 | Spinal Simplicity Receives FDA Clearance for Use of Its Implants as Treatment for Lumbar Spinal Stenosis | Spinal Simplicity Receives FDA Clearance for Use of Its Implants as Treatment for Lumbar Spinal Stenosis December 17, 2021 / Nueterra Capital Marketing Nueterra Capital portfolio company Spinal Simplicity announced that its Minuteman family... |
31.10.2014 | Funding Roundup: Which biotech, medtech and healthIT startups got investments this week? | $33 million in equity raised, closing out a $48 million Series E round The funding will bring Aileron candidate ALRN-6924 – a drug that works to activate a solid tumor suppressor protein called p53 – to clinical trial. The company says its ... |
Show more